BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 4, 2009
View Archived Issues
Ironwood, Forest 'Rooting' for Added Success In IBS
Ironwood Pharmaceuticals Inc. and partner Forest Laboratories Inc. reported positive results from two pivotal Phase III trials of its bowel drug candidate linaclotide in chronic constipation. (BioWorld Today)
Read More
Nabi Aims at Nicotine Addiction with Phase III NicVAX Study
Read More
Resolvin Fights Inflammation While Preservin' Immunity
Read More
Low-Flying Calmune Emerges in Antibody Deal with Crucell
Read More
Other News To Note
Read More
AASL Roundup
Read More
Financings Roundup
Read More
Clinic Roundup
Read More
Earnings Roundup
Read More